Menu
Το καλάθι σας

Non-Small Cell Lung Cancer: New Research

Non-Small Cell Lung Cancer: New Research
Non-Small Cell Lung Cancer: New Research
  • Συγγραφείς: Lina Pasquariello
  • ISBN: 9781624178047
  • Εκδότης: Nova Science Publishers Inc
  • Σελίδες: 191
  • Διαστάσεις: 26 x 18.4cm
  • Έτος Έκδοσης: 2013
103,51€
Χωρίς ΦΠΑ: 97,65€

 

In this book, the authors present current research in the study of non-small cell lung cancer. Topics discussed include the preclinical and clinical advances of epigenetics in lung cancer; therapeutic antibodies and non-coding RNAs (ncRNAs) in non-small cell lung cancer; molecular profiling in lung cancer specimens leads to targeted therapeutic options in patients with non-small cell lung carcinoma; the role of radiation dose escalation in the treatment of stage III locally advanced inoperable non-small cell lung cancer; and mechanisms of resistance to EGFR inhibitors. (Imprint: Nova Biomedical)

 

Table of Contents: 
Preface pp. i-x 

Therapeutic Antibodies in Non-Small Cell Lung Cancer: An Overview and Future Directions 
(L. Guilleminault, E. Lemarié, N. Heuzé-Vourc’h, CEPR « Centre d’étude des Pathologies Respiratoires, Université François Rabelais, Tours, France, and others)pp. 1-76 

Non-Coding RNAs (ncRNAs) in Non-small Cell Lung Cancer (NSCLC) 
(Emanuela Bostjanèiè, Damjan Glavaè, Department of Molecular Genetics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia)pp. 77-106 

Epigenetics in Lung Cancer: Preclinical and Clinical Advances 
(Benjamin F. Chu, Gregory A. Otterson, Department of Medicine, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center and Solove Research Institute, Columbus, OH, USA)pp. 107-128 

Molecular Profiling in Lung Cancer Specimens Leads to Targeted Therapeutic Options in Patients with Non-Small Cell Lung Carcinoma (NSCLC) 
(Kirtee Rapria, Peter Kulesza, Melissa Johnson, Northwestern University, Pathology Department, Chicago, IL, USA)pp. 129-144 

The Role of Radiation Dose Escalation in the Treatment of Stage III Locally Advanced Inoperable Non-Small Cell Lung Cancer: Where Are We Now? 
(Sudha Amarnath, Shilpen Patel, Department of Radiation Oncology, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA)pp. 145-154 

Mechanisms of Resistance to EGFR Inhibitors 
(A. López-González, M. Provencio, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain)pp. 155-164 

Index pp. 165-175

Γράψτε μια αξιολόγηση

Σημείωση: η HTML δεν επεξεργάζεται!
Κακή Καλή